Your AI story has an expiration date
A biotech or SaaS company wants to be seen as an AI company. A health company wants to be seen as a tech company. Some have earned the label. Many are chasing a valuation multiple, knowing capital flows to whoever carries the tag. We’ve seen this script before. During the dot-com boom, adding “.com” to a corporate name could trigger a speculative surge. A decade later, companies rushed to rebrand…
In the world of biotech and SaaS companies, adding "AI" to a corporate name can attract investors seeking valuation multiples. However, this strategy is not a foolproof way to ensure success. During the dot-com boom, companies added ".com" to their names and saw speculative surges, while a decade later, they rushed to rebrand around blockchain.
This is where "the gap" comes into play, the distance between a company's vision and its execution. A young company in stealth mode can afford to stay in this gap for longer, but a well-known brand has less room for error, as reporters, analysts, and competitors closely scrutinize their claims. As the gap widens, external forces such as regulatory scrutiny, public unease, and falling trust can close it for the company.
Companies like WeWork and Apple have experienced this firsthand, with WeWork filing for bankruptcy in 2023 and Apple facing a $250 million settlement over delayed features. To avoid falling into this trap, companies must focus on proof, such as leadership experience, customer validation, and clear problem-solving, rather than relying solely on storytelling. If a company does the work first, category leadership and a higher valuation will typically follow.
Written by urgent.news from Fast Company's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
